title: Has targeted therapy for melanoma made chemotherapy obsolete?
authors.affiliation: Department of Cutaneous Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
authors.forename: Geoffrey T
authors.initials: GT
authors.lastname: Gibney
authors.forename: Vernon K
authors.initials: VK
authors.lastname: Sondak
mesh_terms: D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003606:Dacarbazine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008545:Melanoma / Q000188:drug therapy*; D009154:Mutation; D009382:Neoplasms, Unknown Primary / Q000188:drug therapy*; D048493:Proto-Oncogene Proteins B-raf / Q000235:genetics*; D012878:Skin Neoplasms / Q000188:drug therapy*
chemical_list: D018906:Antineoplastic Agents, Alkylating; D003606:Dacarbazine; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf